• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Permanent atrial fibrillation in women: the prevalent role of risk factors and specific mechanisms determining outcome and quality of life.

作者信息

Savelieva Irina, Camm A John

机构信息

Molecular and Clinical Sciences Institute, St George's University of London, Cranmer Terrace, London SW17 0RE, UK.

出版信息

Europace. 2020 Nov 1;22(11):1603-1606. doi: 10.1093/europace/euaa329.

DOI:10.1093/europace/euaa329
PMID:33175983
Abstract
摘要

相似文献

1
Permanent atrial fibrillation in women: the prevalent role of risk factors and specific mechanisms determining outcome and quality of life.女性永久性心房颤动：危险因素和决定结局及生活质量的特定机制的普遍作用。
Europace. 2020 Nov 1;22(11):1603-1606. doi: 10.1093/europace/euaa329.
2
New-generation atrial antitachycardia pacing (Reactive ATP) is associated with reduced risk of persistent or permanent atrial fibrillation in patients with bradycardia: Results from the MINERVA randomized multicenter international trial.新一代心房抗心动过速起搏（反应性 ATP）与心动过缓患者持续性或永久性心房颤动风险降低相关：MINERVA 随机多中心国际试验的结果。
Heart Rhythm. 2015 Aug;12(8):1717-25. doi: 10.1016/j.hrthm.2015.04.015. Epub 2015 Apr 11.
3
The Ablate and Pace Trial: a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. APT Investigators.消融与起搏试验：一项关于房室传导系统导管消融及永久性起搏器植入治疗心房颤动的前瞻性研究。APT研究人员。
J Interv Card Electrophysiol. 1998 Jun;2(2):121-35. doi: 10.1023/a:1009795330454.
4
Quality of life evidence in the management of the individual patient with atrial fibrillation.房颤个体患者管理中的生活质量证据
Card Electrophysiol Rev. 2003 Jan;7(1):60-2. doi: 10.1023/a:1023647208382.
5
[Atrial fibrillation before and after pacemaker implantation (WI and DDD) in patients with complete atrioventricular block].[完全性房室传导阻滞患者起搏器植入（WI和DDD）前后的心房颤动]
Pol Merkur Lekarski. 2010 May;28(167):345-9.
6
Asymptomatic atrial fibrillation in patients with atrial fibrillation and implanted pacemaker.心房颤动合并植入起搏器患者的无症状性心房颤动
Int J Cardiol. 2017 Jan 15;227:583-588. doi: 10.1016/j.ijcard.2016.10.097. Epub 2016 Nov 5.
7
[Comparison of permanent and paroxysmal atrial fibrillation on the clinical outcome following radiofrequency AV node catheter ablation].[射频房室结导管消融术后永久性房颤与阵发性房颤临床结局的比较]
Z Kardiol. 1999 Oct;88(10):823-7. doi: 10.1007/s003920050358.
8
Long-term outcome of the atrioventricular node ablation and pacemaker implantation for symptomatic refractory atrial fibrillation.症状性难治性心房颤动的房室结消融术和起搏器植入术的长期疗效
Europace. 2008 Apr;10(4):412-8. doi: 10.1093/europace/eun020. Epub 2008 Feb 12.
9
An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation.对阵发性心房颤动患者进行消融和起搏治疗后，通过抗心律失常药物治疗维持窦性心律策略的评估。
Eur Heart J. 2002 Jun;23(11):892-900. doi: 10.1053/euhj.2001.2971.
10
[2010 AIAC Guidelines for the management and treatment of atrial fibrillation].[2010年心房颤动管理与治疗的AIAC指南]
G Ital Cardiol (Rome). 2011 Jan;12(1 Suppl 1):7-69.

引用本文的文献

1
Health-related quality of life and healthcare costs of symptoms and cardiovascular disease events in patients with atrial fibrillation: a longitudinal analysis of 27 countries from the EURObservational Research Programme on Atrial Fibrillation general long-term registry.房颤患者的症状和心血管疾病事件的健康相关生活质量和医疗保健成本：EURObservational Research Programme on Atrial Fibrillation 一般长期注册中心 27 个国家的纵向分析。
Europace. 2024 Jun 3;26(6). doi: 10.1093/europace/euae146.